Addex Therapeutics Ltd (SWX:ADXN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
0.0350
+0.0134 (62.04%)
Nov 12, 2026, 1:57 PM CET

Addex Therapeutics Ratios and Metrics

Millions CHF. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
86661039
Market Cap Growth
15.19%14.83%-9.01%-40.48%-73.65%-25.96%
Enterprise Value
7422024
Last Close Price
0.020.060.060.050.101.04

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--0.80---
PS Ratio
79.6037.3613.723.827.1912.50
PB Ratio
3.461.360.585.402.112.33
P/TBV Ratio
3.461.360.585.402.112.33

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
71.3024.925.661.080.287.76

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.040.010.000.300.080.03
Net Debt / Equity Ratio
-0.36-0.34-0.34-3.07-1.34-1.18
Net Debt / EBITDA Ratio
0.270.571.291.580.631.32
Net Debt / FCF Ratio
0.290.740.610.440.401.36
Asset Turnover
0.010.020.050.250.090.15
Quick Ratio
0.581.384.191.392.305.03
Current Ratio
0.761.404.421.462.385.31
Return on Equity (ROE)
-150.58%-94.75%-90.72%-82.53%-98.92%-97.35%
Return on Assets (ROA)
-27.12%-20.64%-22.48%-21.69%-42.75%-45.37%
Return on Capital Employed (ROCE)
-122.90%-54.50%-27.90%-128.30%-210.80%-84.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-166.16%-104.18%125.46%-170.78%-200.32%-38.95%
FCF Yield
-36.09%-33.62%-95.57%-129.41%-158.28%-37.39%
Buyback Yield / Dilution
-19.49%-9.44%-32.04%-64.45%-32.43%-27.88%